Reddit Posts
Mentions
Well drink one for my large TVGN purchase last night
MAXQF and TVGN were new ones I seen mentioned. 
TVGN volume is crazy high premarket
TVGN is my play today. Hit a 52 week low yesterday and then posted extremely good news on their product. At .50 a share it’s a steal in my opinion. It’s going places.
TVGN and PHGE both had clinically excellent results (expanding product use case) but share price fell. I can only assume investors thought "oh no, they're going to open new trials!" and bailed. Or, in PHGE's case, investors are bailing ahead of earnings. I suspect they'll regret that as PHGE receives non-dilutive grants from the DoW.
Well I’m ending the night with some more TVGN. Hoping their good news brings some action overnight and a run in the morning.
Tevogn (TVGN) just dropped amazing clinical use-case expansion data.
Can someone please look into TVGN and tell if that potato is going to move?
❌ Issues That Hurt Credibility ❗️Incorrect Sector Framing You mention media, entertainment, or tech — but TVGN is a biotech company, working on off-the-shelf T-cell therapies and AI-driven drug development. This disconnect immediately raises red flags for knowledgeable investors or analysts. ❗️Unverified Financial Claims "Recent earnings reports show revenue growth, profitability, and strong cash flow" → This is not accurate. Tevogen is pre-revenue and has no commercialized products. The company is not profitable, and any cash flow likely stems from financing, not operations. ❗️Valuation Metrics Aren’t Applicable Metrics like P/E or PEG don’t apply well to early-stage biotech. These companies typically operate at a loss and rely on pipeline milestones and partnerships, not earnings multiples.
Small cap stocks that might benefit from trumps 70 Billion PR : https://www.bloomberg.com/news/articles/2025-07-14/trump-to-unveil-70-billion-in-ai-and-energy-investments - **$CETX** : ~$0.30 - **$NXE** : ~$4.50 - **$TVGN** : ~$2.50 - **$BTBT** : ~$3.80 - **$FCEL** : ~$0.60 - **$PLUG** : ~$2.80 - **$IDEX** : ~$0.90
TVGN is doing well today
$TVGN Tevogen Bio Broadens Relationship with Microsoft to Deepen Artificial Intelligence Collaboration and Develop PredicTcell Technology on Azure [https://www.barchart.com/story/news/30601579/tevogen-bio-broadens-relationship-with-microsoft-to-deepen-artificial-intelligence-collaboration-and-develop-predictcell-technology-on-azure](https://www.barchart.com/story/news/30601579/tevogen-bio-broadens-relationship-with-microsoft-to-deepen-artificial-intelligence-collaboration-and-develop-predictcell-technology-on-azure)
Your post with title "Tevogen Bio Broadens Relationship with Microsoft to Deepen Artificial Intelligence Collaboration and Develop PredicTcell Technology on Azure ($TVGN)" has been removed from r/pennystocks because it is too short. Posts must have at least 50 characters to ensure meaningful discussions. *I am a bot, and this action was performed automatically. Please [contact the moderators of this subreddit](/message/compose/?to=/r/pennystocks) if you have any questions or concerns.*
TVGN after news, up almost 26% in after hours. Might have a chance to run up Monday.
And tank TVGN so I can buy the dip
We are talking about Tevogen (TVGN) here and they closed out yesterday @ $1.36…and are about to open somewhere in the $1.60-1.70 range due to their most recent Q3 report. 📈 Enjoy your day…And Good Luck.🍀
If I didn't set stop losses today I could have made $5300 from MSOX and TVGN. Instead I made $100. FML
You got it! BITF: > Bitfarms Ltd. (BITF) is showing signs of short-term bullish momentum, driven by Bitcoin’s strong performance and anticipation of upcoming earnings, with a current price of $2.575. The technical indicators are supportive of this trend: the RSI is in overbought territory, suggesting strong buying pressure, while the MACD shows a positive histogram, indicating upward momentum. The stock has recently experienced increased volatility, likely due to speculation about a potential short squeeze, although this remains speculative without a clear catalyst. The broader market is in a robust uptrend, which could further support BITF’s price movement. For today’s trading session, consider a long position with an entry around $2.55, targeting $2.75 as the first price target and $3.00 as the second, with a stop loss at $2.40. Confidence in reaching the first target is moderate, given the current momentum and market conditions, while the second target carries higher risk due to potential volatility. Overall, while optimism for short-term gains exists, caution is advised due to mixed sentiment and speculative nature. TVGN: > Tevogen Bio Holdings Inc. (TVGN) is experiencing a positive sentiment driven by its strategic partnership with Microsoft, enhancing its AI capabilities in drug discovery. Despite the bullish outlook, caution is advised due to its pre-clinical status and potential volatility. The stock’s recent price surge has been significant, but technical indicators like the RSI around 49 suggest it’s not overbought yet. The MACD histogram is negative, indicating bearish momentum, while the current price of $1.54 is below both the 10-day SMA ($1.76) and 20-day EMA ($1.63), suggesting potential downward pressure. Given the broader market’s robust uptrend, TVGN might see some support, but its low volume compared to the 65-day average indicates limited buying interest. For today’s session, consider a SHORT position with an entry at $1.54, targeting $1.40 first and $1.30 second, with a stop loss at $1.60. Confidence in the first target is moderate due to mixed technical signals, while the second target carries lower confidence given the speculative nature of biotech stocks. TPST: > Tempest Therapeutics, Inc. (TPST) is currently trading at $1.1199 with a market cap of approximately $27.98 million and a low trading volume compared to its 65-day average, indicating limited investor interest. The stock’s technical indicators show mixed signals: the 10-day SMA is below the current price, suggesting short-term bullishness, while the MACD histogram is positive, indicating potential upward momentum. However, the RSI values are approaching overbought levels, which could signal a pullback. Given the broader market’s robust uptrend driven by macroeconomic factors, TPST might experience some sympathy gains, but its lack of news and sparse sentiment data suggest caution. For today’s session, consider a long position with an entry around $1.11, targeting $1.15 as the first target and $1.20 as the second, with a stop loss at $1.05. Confidence in reaching the first target is moderate due to the overall market strength, but the second target carries lower confidence given TPST’s low volume and lack of significant catalysts. Keep an eye on broader market movements and any emerging news that could impact TPST’s trajectory.
Sorry, very delayed! TVGN: Tevogen Bio Holdings Inc. (TVGN) is experiencing mixed sentiment with a tilt towards optimism due to strategic partnerships, notably with Microsoft, enhancing its AI-driven drug discovery capabilities. Despite recent price volatility, the stock's current price of $1.64 shows potential for short-term gains, supported by positive news and a cautiously optimistic broader market environment. Technical indicators reveal a bearish bias with the RSI near oversold levels and MACD showing negative momentum, suggesting potential for a rebound. Given the speculative nature of biotech stocks and recent volume spikes, a cautious long position could be considered. Entry at $1.60, with a first target of $1.80 and a second target of $2.00, while setting a stop loss at $1.50, balances risk and reward. Confidence in reaching the first target is moderate at 60%, given the current market sentiment and technical setup, while the second target holds a lower confidence level of 40% due to inherent sector risks. Overall, TVGN presents an opportunity for risk-tolerant investors, but caution is advised due to potential reversals and market volatility. BNOX: Bionomics Limited (BNOX) is currently trading at $0.395 with a market cap of approximately $8.5 million, showing limited engagement and neutral sentiment in the market. The stock has experienced significant volatility recently, with a notable spike in volume and price fluctuations, suggesting speculative interest. Technical indicators reveal an overbought condition with RSI values above 70, indicating potential for a pullback. The MACD histogram is positive, suggesting bullish momentum, but the overall trend remains uncertain due to sparse news and low current volume compared to its 65-day average. Given the broader market's cautiously optimistic sentiment, driven by tech sector strength, BNOX may see some upward movement if it aligns with this trend. For today's session, consider a long position with an entry around $0.39, targeting $0.42 and $0.45, with a stop loss at $0.37. Confidence in reaching the first target is moderate due to recent volatility, while the second target carries lower confidence given the lack of strong market catalysts.
Bro look at TVGN. They are merging with microsoft AI and getting 1B funding. Also ACHR already has millions in government contracts. These are just some small sleepers i feel could blow up
That's what most of my research has turned to. I've bought 10 shares of TVGN after reading that they partnered and getting 1b in funding from Microsoft. Also, bought several of ACHR due to them already having hundreds of millions of government and private contracts plus they will be ready to produce by the end of they year. Of course it's a gamble but these two stuck out to me after hours of reading.
$TVGN just announced a partnership w/ microsoft... today is the day to get in
$TVGN will exponentially grow the next 1-2 weeks
Yeah that's what I'll probably do then. I'm tracking a few new stocks to buy a handful of and see if they really boom or just bust. I think my pick is leaning towards TVGN because I'm up quite a bit since I bought them at 1.62 two weeks ago and they just got 1 billion funding from microsoft and supposed to skyrocket.
Nothing wrong with 1000% gain in 10 days on $TVGN (not sure where your 120% # is coming from). Looks like it went from 0.266 on Oct 9 to $2.94 on Oct 23. Exactly what exit I'm looking for on $MTC and what my shares were filled at on Sept 4 @ 0.266. See, I knew there was a reason to see this post.
Is it too late for $TVGN right now? Wen't from an IPO last year starting at $10 in February--> $.30 2 weeks ago--> $2.75 today. IDK if she's got any momentum left, or if this is the beginning stage of a gold-mine.
I am not sure about the short aspect, but current volatile stocks that may have catalysts around then include. TVGN, VNDA, HOWL and WINT TVGN new biotech. Forcast 1 billion in revenue 18-22 billion over 5 years. They are already 600% up on the month. 300% since I first bought after their forecast. When they report earnings, things could go boom boom. VNDA - They rejected a second takeover bid valued at 8 dollars a share. The stock popped, but is down again and you may find a good price. There must be a reason that insiders think the company is undervalued at 8 dollars a share. HOWL has 2 poster presentations coming up in early November. The stock had been quite volatile since the announcement and is currently up 50%. WINT - They have similar presentations coming up on recent positive study data and meetings with investors at a conference on October 30th.
TVGN is super erratic on the daily but the massive relative volume this quarter suggests some powerful upward energy. Perplexity reported : “The significant drop … can be attributed to several factors: 1. Insider Selling: Neal Flomenberg, the Chief Scientific Officer of Tevogen Bio Holdings, sold a substantial portion of his shares, totaling approximately $1.75 million. This sale was done to satisfy tax obligations related to the vesting and settlement of restricted stock units. 2. Financial Challenges: Despite recent positive developments and projections, Tevogen Bio Holdings faces financial challenges. The company is not currently profitable and has a negative EBITDA. Additionally, short-term obligations exceed liquid assets, which could concern investors about the company’s ability to meet near-term financial commitments.”
i would like to thank whoever mentioned TVGN
I should not have sold TVGN
I feel yah I had 2000 of TVGN and bought at 1.14 and sold 1.80. Oof now it’s over 3$
I bought a few. I read the top gainers article when I searched this. TVGN & LRHC also popped off with a ton of volume. I can actually sell all 3 of these for about 4-10% profit since the time I purchased these (30 seconds b4 this message) lol
[Tevogen Bio’s Effort in Artificial Intelligence, Tevogen AI, Joins Microsoft for Startups, Begins Accelerating drug Development](https://www.globenewswire.com/news-release/2024/10/23/2967800/0/en/Tevogen-Bio-s-Effort-in-Artificial-Intelligence-Tevogen-AI-Joins-Microsoft-for-Startups-Begins-Accelerating-drug-Development.html) \- TVGN TVGNW The TVGN pump continues. TVGN has issued at least one press release every day since October 11. TVGN opened at 30 cents on October 11. Currently $2.80, up 75% today on 66 million traded so far.
If TVGN keeps pumping I’m gonna cum
wow at TVGN, sold too early 
TVGN has an amazing start and makes big technological leaps
RILY: B. Riley Financial, Inc. (RILY) is showing signs of bullish momentum, with the current price at $5.98, above key moving averages (10-day SMA at $5.31 and 8-day EMA at $5.64), indicating a potential continuation of the upward trend. The MACD histogram is positive, suggesting increasing buying pressure, while the RSI levels are approaching overbought territory, which could signal a short-term pullback. Given the broader market's cautious optimism, RILY may benefit from the strength in growth-oriented sectors. For today's session, consider entering a long position around $5.95, with a first price target of $6.20 and a second target of $6.35, supported by recent highs. Set a stop loss at $5.75 to manage downside risk. Confidence in reaching the first target is moderate due to strong technical indicators, while the second target carries lower confidence given potential market volatility. Stay vigilant for any macroeconomic developments that could impact sentiment. TVGN: Tevogen Bio Holdings Inc. (TVGN) is poised for a potential breakout, driven by promising revenue forecasts and operational updates in the biotech sector. The stock has shown significant upward momentum, with the RSI indicating overbought conditions, suggesting strong buying pressure. The MACD histogram supports this bullish sentiment, showing positive divergence. Recent trading volumes have surged, reflecting heightened investor interest, likely due to the company's ambitious revenue projections and positive clinical trial data. Given the current market optimism in technology and healthcare, TVGN could benefit from broader sector strength. For today's session, consider entering around $1.65, with a first target of $1.80 and a second target of $2.00, while setting a stop loss at $1.50 to manage downside risk. Confidence in reaching the first target is high due to strong technical indicators, while the second target holds moderate confidence, contingent on sustained buying interest and favorable news developments. CYCC: Cyclacel Pharmaceuticals, Inc (CYCC) has shown significant volatility over the past month, with a recent surge in volume and price, indicating heightened interest. The stock's RSI levels are extremely overbought, suggesting potential for a pullback, but the strong MACD histogram indicates bullish momentum may continue. The 8-day EMA is above the 20-day EMA, reinforcing the short-term uptrend. Given the broader market's cautious optimism, CYCC could benefit from the tech sector's strength, though its low market cap and lack of current news make it susceptible to sharp moves. For today's session, consider entering around $1.45, with a first target at $1.60 and a second at $1.75, while setting a stop loss at $1.35 to manage risk. Confidence in reaching the first target is moderate due to technical momentum, but lower for the second target given potential market headwinds. Traders should remain vigilant for any sudden shifts in sentiment or volume spikes. EFSH: 1847 Holdings LLC (EFSH) has shown significant volatility over the past month, with a recent downtrend from highs around $4.57 to the current price of $2.05. The technical indicators suggest a mixed outlook; the MACD histogram is positive, indicating potential bullish momentum, but the RSI hovers near neutral, suggesting indecision. The stock's 8-day EMA at $2.34 is above the current price, indicating potential resistance. Given the broader market's cautious optimism and EFSH's low trading volume, a short position could be considered if the price breaks below $2.00. Entry at $2.00, with a first target of $1.80 and a second target of $1.60, while setting a stop loss at $2.20, aligns with the recent support and resistance levels. Confidence in reaching the first target is moderate due to the stock's volatility, while the second target carries lower confidence given potential market support. Overall, traders should remain vigilant for any sudden shifts in market sentiment or unexpected news impacting EFSH.
Yep, I wrote about some other stock as well and I was right. Name one person here who was always right. And dude, since this post TVGN 3 times went above $2. From $1.3. that's 60-70 %. And it's still $1.80.
Calls on biotech but TVGN specifically is my play
NVDA MSTR ORCL DJT TVGN UPB. Top 3 deffo to keep and hold.
TVGN > IOVA for clinical cancer treatment potential
That’s not entirely how retail trader psychology works. $DRUG for example is up 5000% on the week. $VTAK on the contrary is only up 400%. It is a substantial gain, but it’s in the same situation as $NUZE, $VS, and $TVGN for example. These are names that did not gain enough of a gain to combat a short seller spike, and decreasing momentum. $VTAK also happens to be the smallest market cap of all of them. If the market turns at all from green to red, these names get dumped like crazy. $VTAK holds no merit compared to $DRUG and $SOBR; they have news relating to their respective jumps. This will 100% end badly for those who stay too long.
Thoughts on TVGN and their medicine pipeline announcement?
TVGN has legs man, watch after the market closes. I predict the surge and price…. Maybe I’m wrong. I’ve been in DRUG all day too, hard for me to focus on so many at once. Wish you the best 🤑💎🙏🏼
Thoughts on TVGN? Looks promising with their revenue targets.
Im bought TVGN at 1.25 and no sold single share!!
Iv been following Drug and TVGN both are up 50% today .... Man what I wouldn't do for a 48 hr time machine 
Just made a pretty penny on TVGN
I made sick profit the other day on TVGN. It does have some momentum. So I buy 100 shares. It’s on my main screen. I’ll keep an eye on it. I got my stop set let it rip.
Ok 24y/o, first year out of college. I am a dummy for this I know but... Had a holdings in $SPY and $ASTS which equated to about $13k. After watching what happened to $DRUG on Tuesday I got kinda got theoretically drunk with the thought of making hundreds of thousands and full ported into $TPSC, lost $4,000, panicked and threw what I had left into $TVGN around noon today and lost another $2,000 and now I just sold everything. I feel so stupid, I just told my boss I feel sick and left work. How cope? What do? ( .\_.)
Yooooo I know this sounds like spam but Obi is the real deal fr. Been on his discord for a minute now and made some nice profits off $LASE and $TVGN  TVGN still mooning too after I sold. Not every alert is a homer but his track record is impressive from what I've seen so far
Not sure who pointed out TVGN but thank you.
TVGN +90% today (penny stock)
TVGN +80% today (penny stock)
Yeah, watching HOLO tank…. Look like shorties are Winning on this one Look at TVGN for god sake…. 🚀🚀🚀
[Tevogen Bio Oncology Reports Top-Line Revenue Forecast of $1 Billion in Launch Year and Cumulative 5-Year Estimate Between $10 Billion and $14 Billion; Forecasts for Non-Oncology Therapeutic Areas to Follow](https://www.globenewswire.com/news-release/2024/10/17/2964973/0/en/Tevogen-Bio-Oncology-Reports-Top-Line-Revenue-Forecast-of-1-Billion-in-Launch-Year-and-Cumulative-5-Year-Estimate-Between-10-Billion-and-14-Billion-Forecasts-for-Non-Oncology-Thera.html) \- TVGN TVGNW TVGN has issued at least one, sometimes two PRs every day since last Friday. Up 60% to $1.66 on 52 million shares traded in first 30 minutes today.
Put the wrong ticker up there TVGN
I joined this out of curiosity. They play a lot of penny stocks for paper trades. TVGN and DRUG were on the menu yesterday. As well as SMCI. I have another service which is far far cheaper which also recommended SMCI as a high risk trade but a strike price much closer to reality. Atlantic was a $60C and my other was a $50C. While both calls are worth more I’m glad I went with a 50C. Plenty of degens in there throwing gobs of money at bad trades. I followed some of their trades that gained me very small amounts of money. There are services out there from fidelity for $25/$35month I would recommend before this one. Hell Nate bear has stuff I would pay for before this. Anyways I have to spend 30 minutes trying to figure out how to cancel this subscription today. They love their falling wedge and other standard signals. I have a suspicion that Atlantic is just some 19-20 year olds in Europe that play in the market. They do some live trading and dude sounds young. They aren’t for me, I’ve done well on the Q’s and other DD plays. I will stick with my cheap yearly service and fidelity. They have done well for me.
noticed a couple of ppl getting TVGN. might be worth a look
Anybody know if that is what is happening with TVGN? They had good news, but it is rare that a biotech company goes up 300% on a phase 1 study.
my best guess is [Proequities Inc](https://fintel.io/i13f/proequities/2024-09-30-0) they also got STEC and TVGN both just had a tuesday like drug's monday
U guys think TVGN is gonna keep going tmr or insta dump
[Tevogen Bio Plans to Share $1B+ Revenue Potential of its Pipeline Portfolio Beginning Week of October 14, 2024](https://www.globenewswire.com/news-release/2024/10/11/2962177/0/en/Tevogen-Bio-Plans-to-Share-1B-Revenue-Potential-of-its-Pipeline-Portfolio-Beginning-Week-of-October-14-2024.html) \- TVGN TVGNW Above press release was issued last Friday after market close. Today, TVGN closed at $1.09, up 190%, on 250 million shares traded. TVGNW closed at $0.0337, up 125%, 520k traded. [Tevogen CEO Reaffirms the Company’s Commitment to Closing the Information Gap on Its Multi-Billion-Dollar Assets, Following the Release of Revenue Projections](https://www.globenewswire.com/news-release/2024/10/14/2962874/0/en/Tevogen-CEO-Reaffirms-the-Company-s-Commitment-to-Closing-the-Information-Gap-on-Its-Multi-Billion-Dollar-Assets-Following-the-Release-of-Revenue-Projections.html) Today after market close. " Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified T cell therapeutics to treat infectious disease and cancers, plans to update shareholders on multi-billion dollar asset valuation following this week’s $1b+ revenue potential announcement." "This week, we will report on the substantial revenue potential of our pipeline, and in the near future, we will provide a comprehensive update on our asset valuation,” remarked Ryan Saadi, MD, MPH, Founding CEO, and 2023 Nobel Nominee." Key Achievements: "Tevogen Bio is recognized as the highest valued biotech unicorn of 2022, with an independent $4.2 billion valuation."
TVGN moving like a crypto meme coin
See below pump and dump stocks below in today market wat is SEC doing ✅1️⃣ TVGN Long > 5.17 Short < 4.60 ✅2️⃣ RELI Long > 0.6210 Short < 0.5399 ✅3️⃣ HWH Long >2.49 Short < 2.25 ✅4️⃣ ZCMD Long > 2.10 Short < 1.91 ✅5️⃣ CADL Long > 2.09 Short < 1.87
Those are junk stocks ' - see message below Some random site published this at 8.50 am ✅1️⃣ TVGN Long > 5.17 Short < 4.60 ✅2️⃣ RELI Long > 0.6210 Short < 0.5399 ✅3️⃣ HWH Long >2.49 Short < 2.25 ✅4️⃣ ZCMD Long > 2.10 Short < 1.91 ✅5️⃣ CADL Long > 2.09 Short <1.97